CorMedix Inc
CRMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$659M
Close$
$-0.37
104.4% downside
Current Fair Value
104.4% downsideOvervalued by 104.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $659.00 Million |
|---|---|
| Enterprise Value | $625.79 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.25 |
| Beta | 1.48 |
| Outstanding Shares | 79,509,000 |
Return
| Return on Equity | 24856.58% |
|---|---|
| Return on Assets | 13319.09% |
| Return on Invested Capital | 7812.94% |
Valuation & Multiples
| P/E Ratio | 3.53 |
|---|---|
| PEG | 4.06 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 1.65 |
| Enterprise Value to Revenue | 0.01 |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$0.35
Average shareholder expectationRevenue Estimate
$104.96 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$0.26
Average shareholder expectationRevenue Estimate
$96.04 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 111.30% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.55%▼ 56.56% |
|---|---|
| Total Invested | $3.45M▼ 98.77% |
| Investors Holding | 3▼ 197.00% |
ESG Score
No data
About CorMedix Inc
CEO: Khoso Baluch